Beta Drugs Share Price Today | Stock Price & Beta Drugs Share Screener

Track the current stock price of Beta Drugs with an interactive chart. Analyse BETA share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Beta Drugs stock quote in one place.

The quote of ₹2,004.00 sits between the 52-week low of ₹1,030.30 and the 52-week high of ₹2,668.30, and the latest session moved -3.34% from the previous close.

Screen Beta Drugs company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for BETA shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE351Y01019.

Classification

Identifiers and Leadership

Screen BETA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹496, up from ₹436 in 2025.

Latest statistics put total assets at ₹496 and shareholder funds at ₹245, with a leverage ratio of 0.43.

Screen Beta Drugs income statement and profit fundamentals. Analyze BETA quarterly results. Beta Drugs reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Jun, revenue was ₹127 and net profit was ₹17, equal to earnings per unit of ₹14.78, at an operating margin of 22%.

In that period expenses were ₹98, interest cost ₹3 and tax ₹6. The next period listed, 2026-Mar, shows revenue of ₹97 and net profit of ₹9.

Screen BETA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2025-March, operating activities generated ₹36, and net cash flow was an inflow of ₹118.

Over the same period, investing activities used ₹36 and financing activities provided ₹118.

See Beta Drugs shareholding pattern with promoter, FII, and DII holdings. Check Beta Drugs promoter holding and ownership changes for BETA on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Jun, promoters held 59.10%, foreign institutions 1.02%, domestic institutions 6.23% and the public 24.30%, spread across 7,359 shareholders.

The shareholder count was 7,359 in 2026-Jun, compared with 5,027 in 2026-May.

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Beta Drugs. Beta Drugs dividend yield can be compared with peers and other stocks in the market.

See which indices include Beta Drugs stock. Check BETA index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Get Beta Drugs corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Beta Drugs stock events that may affect BETA share price, along with derivatives, futures and options activity and sector gainers.

11 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated July 20, 2026, with a record date of July 20, 2026.

It is followed by Quarterly Result Announcement dated May 14, 2026 and Quarterly Result Announcement dated February 14, 2026.

Screen BETA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Screen BETA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated September 28, 2026.

The next most recent announcements are dated September 10, 2026 and September 7, 2026.

Quotes are sourced from the NSE. Key statistics were last updated on October 6, 2026. This page covers 9 balance sheet periods, 7 income statement periods, 8 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.